Department of Population Health Research, Alberta Health Services-Cancer Care, Box ACB, 2210-2nd St SW, Calgary, AB T2S 3C3, Canada.
Cancer Causes Control. 2013 Mar;24(3):451-61. doi: 10.1007/s10552-012-0131-7. Epub 2012 Dec 28.
Alcohol consumption may be a modifiable risk factor for prostate cancer, but previous results have been inconsistent and limited by a lack of data on lifetime exposure and specific beverages. Furthermore, the effect of tumor stage and severity of disease on the association between alcohol and prostate cancer risk has not been fully investigated.
We examined the relation between both current and lifetime alcohol intake and prostate cancer risk in a population-based case-control study in Alberta, Canada with 947 cases with stage T2 and higher prostate cancer diagnosed between 1997 and 2000 and frequency matched to 1,039 controls, identified through random digit dialing. Cases were classified on cancer stage and severity into 619 non-aggressive (Stage II and Gleason score <8) and 328 aggressive cases (Stage III/IV or Gleason score ≥8). In-person interviews were completed on current and lifetime history of alcohol consumption and all other prostate cancer risk factors.
Current alcohol intake did not increase prostate cancer risk but lifetime intake increased risk for both non-aggressive and aggressive cases, with an odds ratio of 1.78 (95 % CI 1.19-2.66) and 2.00 (95 % CI 1.19-3.36), respectively, for the highest intake quartile compared to non-drinkers with evidence for a linear trend. Associations with alcohol intake remained after exclusion of non-drinkers for non-aggressive prostate cancer cases. Only lifetime beer intake was significantly associated with increased risk, however, intakes of liquor and wine by participants were low.
Results support the evidence for an increased risk of prostate cancer from lifetime alcohol consumption.
饮酒可能是前列腺癌的一个可改变的风险因素,但以前的结果不一致,并且由于缺乏关于终生暴露和特定饮料的数据而受到限制。此外,肿瘤分期和疾病严重程度对酒精与前列腺癌风险之间的关联的影响尚未得到充分研究。
我们在加拿大阿尔伯塔省进行了一项基于人群的病例对照研究,研究了当前和终生饮酒与前列腺癌风险之间的关系,该研究纳入了 947 例在 1997 年至 2000 年间诊断为 T2 及以上前列腺癌的病例和通过随机数字拨号确定的 1039 例频数匹配对照。根据癌症分期和严重程度,病例分为 619 例非侵袭性(分期 II 和 Gleason 评分<8)和 328 例侵袭性病例(分期 III/IV 或 Gleason 评分≥8)。通过面对面访谈完成了当前和终生饮酒史以及所有其他前列腺癌危险因素的调查。
当前饮酒并未增加前列腺癌风险,但终生饮酒增加了非侵袭性和侵袭性病例的风险,最高饮酒四分位组的比值比分别为 1.78(95%CI 1.19-2.66)和 2.00(95%CI 1.19-3.36),与非饮酒者相比呈线性趋势。在排除非侵袭性前列腺癌病例中的非饮酒者后,与饮酒摄入的关联仍然存在。只有终生啤酒摄入与风险增加显著相关,但参与者的白酒和葡萄酒摄入量较低。
结果支持终生饮酒与前列腺癌风险增加的证据。